These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 19130409)

  • 1. Natriuretic peptides in heart failure: their role in daily practice.
    Loboz-Grudzień K; Jaroch J
    Cardiol J; 2009; 16(1):1-3. PubMed ID: 19130409
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Natriuretic peptides as cardiac markers in clinical practice].
    Veien KT; Jensen JK; Hildebrandt P; Gøtze JP; Nielsen OW; Køber L
    Ugeskr Laeger; 2010 Jul; 172(30):2111-6. PubMed ID: 20654278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
    Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is plasma N-BNP a good indicator of the functional reserve of failing hearts? The FRESH-BNP study.
    Williams SG; Ng LL; O'Brien RJ; Taylor S; Wright DJ; Tan LB
    Eur J Heart Fail; 2004 Dec; 6(7):891-900. PubMed ID: 15556051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How does volume status affect BNP and troponin levels as markers of cardiovascular status in peritoneal dialysis?
    Garg R; Singh A; Khaja A; Martin A; Aggarwal K
    Congest Heart Fail; 2009; 15(5):240-4. PubMed ID: 19751426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-type natriuretic peptide is an independent predictor for cardiovascular death in patients with no clinical signs of ventricular dysfunction after acute myocardial infarction.
    Zhang Y; Wang L
    Med Hypotheses; 2006; 67(5):1076-8. PubMed ID: 16697117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of brain natriuretic peptide (BNP) measurement in cardiovascular disease.
    Sullivan DR; West M; Jeremy R
    Heart Lung Circ; 2005 Jun; 14(2):78-84. PubMed ID: 16352258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen uptake efficiency slope correlates with brain natriuretic peptide in patients with heart failure.
    Straburzyńska-Migaj E; Gwizdała A; Siniawski A; Ochotny R; Grajek S
    Cardiol J; 2010; 17(4):362-6. PubMed ID: 20690091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis in heart failure with a normal ejection fraction.
    Cleland JG; Taylor J; Tendera M
    N Engl J Med; 2007 Aug; 357(8):829-30. PubMed ID: 17715420
    [No Abstract]   [Full Text] [Related]  

  • 11. Improving risk stratification for heart failure. A role for serial testing of B-type natriuretic peptides?
    Daly MG; Frampton CM; Troughton RW
    J Am Coll Cardiol; 2010 Feb; 55(5):451-3. PubMed ID: 20117458
    [No Abstract]   [Full Text] [Related]  

  • 12. Congenital heart disease, exercise capacity and B-type natriuretic peptide.
    Carvalho VO
    Cardiol J; 2009; 16(5):489; author reply 490. PubMed ID: 19753535
    [No Abstract]   [Full Text] [Related]  

  • 13. Slightly elevated B-type natriuretic peptide levels in a non-heart failure range indicate a worse left ventricular diastolic function in individuals with, as compared with individuals without, type 2 diabetes: the Hoorn Study.
    van den Hurk K; Alssema M; Kamp O; Henry RM; Stehouwer CD; Diamant M; Boomsma F; Heine RJ; Nijpels G; Paulus WJ; Dekker JM
    Eur J Heart Fail; 2010 Sep; 12(9):958-65. PubMed ID: 20667891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of b-type natriuretic peptide in heart failure management.
    Newton PJ; Betihavas V; Macdonald P
    Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Learning to use a biomarker. More about B-type natriuretic peptide.
    Mills RM
    J Am Coll Cardiol; 2008 Jun; 51(24):2336-8. PubMed ID: 18549919
    [No Abstract]   [Full Text] [Related]  

  • 16. Serial BNP assay in monitoring exercise tolerance in patients with diastolic dysfunction.
    Romano S; di Mauro M; Fratini S; Furia N; Ciampini V; Gallina S; Penco M
    Int J Cardiol; 2011 Mar; 147(2):312-3. PubMed ID: 21215475
    [No Abstract]   [Full Text] [Related]  

  • 17. BNP or NTproBNP? A clinician's perspective.
    Steiner J; Guglin M
    Int J Cardiol; 2008 Sep; 129(1):5-14. PubMed ID: 18378336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis].
    Dahlström U; Alehagen U
    Lakartidningen; 2006 Mar 22-28; 103(12):927-9. PubMed ID: 16618036
    [No Abstract]   [Full Text] [Related]  

  • 19. When renal and cardiac insufficiencies intersect: is there a role for natriuretic peptide testing in the 'cardio-renal syndrome'?
    van Kimmenade RR; Pinto Y; Januzzi JL
    Eur Heart J; 2007 Dec; 28(24):2960-1. PubMed ID: 17984131
    [No Abstract]   [Full Text] [Related]  

  • 20. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.
    Tang WH; Francis GS; Morrow DA; Newby LK; Cannon CP; Jesse RL; Storrow AB; Christenson RH; Apple FS; Ravkilde J; Wu AH;
    Circulation; 2007 Jul; 116(5):e99-109. PubMed ID: 17630410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.